Fecal transplant turns cancer immunotherapy non-responders into responders

Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy—which has a failure rate of 40% for this type of cancer—into patients who do.

Author:

Leave a Reply

Your email address will not be published. Required fields are marked *